Sunscreen Meetings

The following is a list of meetings that have occurred between FDA and stakeholders on the topic of sunscreens.

---

Date	Type of Meeting	Organization	Meeting Materials
November 1, 2024	Listening Session	Environmental Working Group (EWG)	Meeting Request Meeting Materials Meeting Minutes
April 18, 2024	Listening Session	American Academy of Dermatology Association (AADA)	Meeting Request Meeting Materials Meeting Minutes
December 1, 2023	Listening Session	Public Access to Sunscreen Coalition (PASS)	Meeting Request Meeting Minutes PASS Follow-up Letter
August 18, 2023	MGF 400074 Type Z	Personal Care Products Council (PCPC)	Meeting Request Meeting Granted Meeting Package FDA Preliminary Comments PCPC Response to FDA Preliminary Comments Meeting Minutes PCPC Withdrawal from OTC Sunscreen Industry Working Group Clinical and Nonclinical Safety Work Plan for Active Ingredients in Over-the-Counter Sunscreen Drug Products submission from Integral Integral Withdrawal from OTC Sunscreen Industry Working Group FDA First Advice Letter to Covington & Burling FDA Second Advice Letter to Covington & Burling Covington Withdrawal from OTC Sunscreen Industry Working Group FDA Advice Letter to Consumer Healthcare Products Association (CHPA) CHPA Response to FDA Advice Letter
March 24, 2023	MGF 400062 Type Z	Personal Care Products Council (PCPC)	Meeting Request Meeting Granted Meeting Package FDA Preliminary Comments PCPC Response to FDA Preliminary Comments Meeting Minutes
December 6, 2022	MGF 400060 Type Z	Personal Care Products Council (PCPC)	Meeting Request Unacceptable for Formal Meeting Request Letter
March 22, 2022	MGF 400005	EMD Performance Materials Corp. & Avon Company	Meeting Request Meeting Request Acknowledgement Meeting Denied
April 23, 2021	Listening Session	Environmental Working Group (EWG)	Meeting Minutes
April 20, 2021	Listening Session	Public Access to Sunscreen Coalition (PASS)	Meeting Minutes PASS Follow- up Letter
March 17, 2021	MGF 400000 (see note)	Personal Care Products Council (PCPC)	Meeting Request Meeting Granted Meeting Materials OTC Industry Working Group Contact Change Unacceptable for Formal Meeting Request Letter Meeting Cancellation
November 13, 2019	Public Meeting	Personal Care Products Council (PCPC)	Meeting Request Meeting Granted Meeting Package FDA Preliminary Comments Announcement Granting PCPC Request for Meeting Postponement Second Announcement Granting PCPC Request for Meeting Postponement
June 7, 2019	Non-Public Meeting	DSM Nutritional Products LLC (DSM)	Meeting Request Meeting Granted Meeting Minutes
October 12, 2017	Non-Public Meeting	BASF Corp	Meeting Request Meeting Granted Meeting Package Meeting Minutes
September 7, 2016	Meeting	Personal Care Products Council (PCPC)	Meeting Request Meeting Minutes
May 11, 2015	Meeting	L'Oréal USA Products Inc.	Meeting Granted Meeting Minutes L'Oreal Response to FDA Meeting Minutes FDA Advice Letter
March 20, 2015	Meeting	BASF SE	Meeting Granted Meeting Minutes
March 19, 2015	Meeting	BASF SE	Meeting Granted (also available at FDA-2005-N-0453-0041) Meeting Minutes (also available at FDA-2005-N-0453-0042) FDA Advice Letter (also available at FDA-2005-N-0453-0046)
March 18, 2015	Meeting	L'Oréal USA Products Inc.	Meeting Granted Meeting Cancellation
February 4, 2015	Meeting	CHPA, EWG, PCPC, and PASS	Meeting Announcement Summary of Meeting Meeting Materials

---

Note: The Coronavirus Aid, Relief and Economic Security (CARES) Act was enacted on March 27, 2020, and included important provisions reforming the way that OTC monograph drugs are regulated in the US. Among other things, the CARES Act replaced the previous rulemaking process for establishing, revising, and amending OTC monographs with an administrative order process. See OTC Monograph Resources for more information about OTC monograph reform and drug regulation under the CARES Act.

Related Resources

• Sunscreen Innovation Act | FDA
• Regulatory Policy Information | Sunscreen Innovation Act | FDA
• Rulemaking History for OTC Sunscreen Drug Products | FDA